Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 28

Sort by

Sort Order Select

Journal Articles

Chemotherapy Dose Reductions and Dose Delays Due to Thrombocytopenia

Gautham Prakash, Kelsey Pandrangi, Ranya Khateeb, Shivi Jain

Blood (2022) 140 (Supplement 1): 11248–11249.

https://doi.org/10.1182/blood-2022-171193

Published: 2022

Journal Articles

Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19

Shivani Rao, Nicole K. Yun, James L. Coggan, Peter Wu, Teresa O'Brien, Katherine Barnett, Sean O'Mahony, Ramandeep Kaur, Christopher Bruti, Celine Goetz, Jerome J Martin, Sefer Gezer, Parameswaran Venugopal, Shivi Jain

Blood (2021) 138 (Supplement 1): 4179.

https://doi.org/10.1182/blood-2021-151985

Published: 2021

Journal Articles

Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic

Blood (2021) 138 (Supplement 1): 4178.

https://doi.org/10.1182/blood-2021-151913

Published: 2021

Journal Articles

Pharmacokinetic / Pharmacodynamic (PK/PD) Simulations Guide Selection of the Dose for Administration of Efgartigimod Subcutaneously in a Phase 3 Clinical Trial in Patients with Primary Immune Thrombocytopenia

Waleed Ghanima, Vickie McDonald, Shivi Jain, Monica Carpenedo, Esther N. Oliva, Anna Hultberg, Domenica Gandini, Erik Hofman, Tonke Van Bragt, Wim Parys, Benjamin van Hoorick, Yoshitaka Miyakawa, Catherine M. Broome

Blood (2021) 138 (Supplement 1): 3165.

https://doi.org/10.1182/blood-2021-153261

Published: 2021

Journal Articles

Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies

Elizabeth Behrens, MD, Anne Timmermann, Alexander Yerkan, Deborah A. Katz, MD, Agne Paner, MD, Melissa C. Larson, MD, Seo-Hyun Kim, MD, Shivi Jain, MDMBBS, Sefer Gezer, MD, Parameswaran Venugopal, MD, Irene Dehghan-Paz, Yoona Rhee, Celalettin Ustun, MD, Ankur Varma, Jamile M. Shammo, MD

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141063

Published: 2020

Journal Articles

Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients

Surbhi Warrior, MDMPH, Elizabeth Behrens, MD, Joshua Thomas, MD, Priya Rajakumar, MD, Sefer Gezer, MD, Parameswaran Venugopal, MD, Shivi Jain, MDMBBS

Blood (2020) 136 (Supplement 1): 6–7.

https://doi.org/10.1182/blood-2020-137707

Published: 2020

Journal Articles

Thrombosis and Mortality in Pregnant Patients with COVID-19

Elizabeth Behrens, MD, Surbhi Warrior, MDMPH, Joshua Thomas, MD, Xavier Pombar, DO, Sefer Gezer, MD, Parameswaran Venugopal, MD, Shivi Jain, MDMBBS

Blood (2020) 136 (Supplement 1): 8–9.

https://doi.org/10.1182/blood-2020-137779

Published: 2020

Journal Articles

Impact of Blood Group Type on Severity of Disease in COVID-19 Patients

Shivani Rao, Surbhi Warrior, MDMPH, Sefer Gezer, MD, Parameswaran Venugopal, MD, Shivi Jain, MDMBBS

Blood (2020) 136 (Supplement 1): 29.

https://doi.org/10.1182/blood-2020-139021

Published: 2020

Journal Articles

Durability of Initial Platelet Count Response in Patients Treated with Avatrombopag for Immune Thrombocytopenia (ITP): Post-Hoc Results from a Phase 3 Clinical Study

Shivi Jain, MDMBBS, Matthew Wojdyla, PharmD, Michael Vredenburg, PhD, Brian Jamieson, MDBA, Terry B. Gernsheimer, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-142764

Published: 2020

Journal Articles

Heparin Induced Thrombocytopenia in Patients with COVID-19

Surbhi Warrior, MDMPH, Elizabeth Behrens, MD, Sefer Gezer, MD, Parameswaran Venugopal, MD, Shivi Jain, MDMBBS

Blood (2020) 136 (Supplement 1): 17–18.

https://doi.org/10.1182/blood-2020-134702

Published: 2020

Journal Articles

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Faiz Ahmed Hussain, MD, Shivi Jain, MD, Laura Kavoliunaite, APN, Robert E. Molokie, MD, Victor R Gordeuk, MD

Blood (2019) 134 (Supplement_1): 3390.

https://doi.org/10.1182/blood-2019-122249

Published: 2019

Journal Articles

Kidney Ultrasound Findings in Sickle Cell Anemia According to Kidney Disease and the APOL1 G1/G2 Risk Variants

Sandra Kang, MD, Rishi Patel, MD, Ali Kord Valeshabad, MD, Binal N. Shah, PhD, Rishabh Choudhari, Dallas De La Vara, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Karen Xie, MD, James P. Lash, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 3663.

https://doi.org/10.1182/blood-2018-99-113637

Published: 2018

Journal Articles

Pulmonary Function Abnormalities in Adults with Sickle Cell Anemia

Adam Rock, MD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Rasha Raslan, MD, Michel Gowhari, DO, Shivi Jain, MD, Xu Zhang, PhD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 3664.

https://doi.org/10.1182/blood-2018-99-114820

Published: 2018

Journal Articles

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Jin Han, PharmD, PhD, Santosh L. Saraf, MD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 4699.

https://doi.org/10.1182/blood-2018-99-114733

Published: 2018

Journal Articles

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

Shivi Jain, MD, Andrew Srisuwananukorn, MD, Santosh L. Saraf, MD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Victor R. Gordeuk, MD

Blood (2018) 132 (Supplement 1): 1087.

https://doi.org/10.1182/blood-2018-99-115508

Published: 2018

Journal Articles

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

Andrew Srisuwananukorn, MD, Rasha Raslan, MD, Xu Zhang, PhD, Binal N. Shah, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Santosh L. Saraf, MD

Blood (2018) 132 (Supplement 1): 9.

https://doi.org/10.1182/blood-2018-99-115128

Published: 2018

Journal Articles

Role of Automated Red Cell Exchange in Acute and Chronic Complications of Sickle Cell Disease

Shivi Jain, MD, Adam Rock, MD, Caitlin Lopes, Santosh L. Saraf, MD, Xu Zhang, PhD, Michel Gowhari, DO, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Sally Campbell-lee, MD

Blood (2018) 132 (Supplement 1): 3674.

https://doi.org/10.1182/blood-2018-99-115677

Published: 2018

Journal Articles

Health Care Utilization in Transplanted Versus Non-Transplanted Sickle Cell Disease Patients

Santosh L. Saraf, MD, Krishna Ghimire, MD, Pritesh Patel, MD, Karen Sweiss, PharmD, John G. Quigley, Irum Khan, MBBS, David Peace, MD, Michel Gowhari, DO, Shivi Jain, MD, John P. Galvin, MDMS,MPH, Robert E. Molokie, MD, Victor R. Gordeuk, MD, Damiano Rondelli, MD

Blood (2018) 132 (Supplement 1): 313.

https://doi.org/10.1182/blood-2018-99-113666

Published: 2018

Journal Articles

HMOX1 and acute kidney injury in sickle cell anemia

Santosh L. Saraf, Maya Viner, Ariel Rischall, Rasha Raslan, Binal N. Shah, Xu Zhang, Jin Han, Michel Gowhari, Shivi Jain, Robert E. Molokie, Roberto F. Machado, James P. Lash, Victor R. Gordeuk

Blood (2018) 132 (15): 1621–1625.

https://doi.org/10.1182/blood-2018-05-853929

Published: 2018

Includes: Supplemental data

Journal Articles

HMOX1 and Acute Kidney Injury in Sickle Cell Anemia

Santosh L. Saraf, MD, Maya Viner, MD, Ariel Rischall, MD, Binal Shah, PhD, Xu Zhang, PhD, Jin Han, PharmD, PhD, Michel Gowhari, DO, Shivi Jain, MD, Robert E. Molokie, MD, Roberto F. Machado, MD, James P. Lash, MD, Victor R. Gordeuk, MD

Blood (2017) 130 (Supplement 1): 686.

https://doi.org/10.1182/blood.V130.Suppl_1.686.686

Published: 2017

NARROW

Chemotherapy Dose Reductions and Dose Delays Due to Thrombocytopenia

Retrospective Study Evaluating Effect of Voxelotor Treatment on Acute Care Utilization during the Peak of COVID-19

Impact of Crizanlizumab on Acute Medical Care Utilization in the Height of the COVID-19 Pandemic

Pharmacokinetic / Pharmacodynamic (PK/PD) Simulations Guide Selection of the Dose for Administration of Efgartigimod Subcutaneously in a Phase 3 Clinical Trial in Patients with Primary Immune Thrombocytopenia

Outcomes of COVID-19 Infection in Patients with Hematologic Malignancies

Impact of Treatment and Anticoagulation on Thrombosis in COVID-19 Patients

Thrombosis and Mortality in Pregnant Patients with COVID-19

Impact of Blood Group Type on Severity of Disease in COVID-19 Patients

Durability of Initial Platelet Count Response in Patients Treated with Avatrombopag for Immune Thrombocytopenia (ITP): Post-Hoc Results from a Phase 3 Clinical Study

Heparin Induced Thrombocytopenia in Patients with COVID-19

Impact of Intravenous Opioid Shortage on Managing Pain Crisis in Sickle Cell Disease

Kidney Ultrasound Findings in Sickle Cell Anemia According to Kidney Disease and the APOL1 G1/G2 Risk Variants

Pulmonary Function Abnormalities in Adults with Sickle Cell Anemia

Association of Inpatient Opioid Utilization and Readmission Risk in Sickle Cell Disease

Cancer Incidence in Sickle Cell Disease:an Institutional Experience

Clinical, Laboratory, and Genetic Risk Factors for Thrombosis in Sickle Cell Disease

Role of Automated Red Cell Exchange in Acute and Chronic Complications of Sickle Cell Disease

Health Care Utilization in Transplanted Versus Non-Transplanted Sickle Cell Disease Patients

HMOX1 and acute kidney injury in sickle cell anemia

HMOX1 and Acute Kidney Injury in Sickle Cell Anemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only